Acute myocardial infarction triggered by influenza: Role of vaccine in its prevention

Authors

Nischit Baral, BP Koirala Institute of Health Sciences, Dharan, NepalFollow
Suman Sharma, Department of Internal Medicine, Guthrie Robert Packer Hospital, Pennsylvania, USAFollow
Subash Ghimire, Department of Internal Medicine, Guthrie Robert Packer Hospital, Pennsylvania, USAFollow
Sanjay Poudel, BP Koirala Institute of Health Sciences, Dharan, NepalFollow
Savyata Hamal, Department of Internal Medicine, Long Island Jewish Forest Hills Northwell Health, New YorkFollow
Nisha Baral, Department of Microbiology, Gandaki Medical College, Pokhara, NepalFollow
Niranjan Nayak, Department of Microbiology, Manipal College of Medical Sciences, Pokhara, NepalFollow

Abstract

Influenza is a major cause of hospitalization in all age groups. Cardiovascular complications due to influenza are important causes of morbidity and mortality in the US, especially in the elderly population (aged more than 65 years). Acute Myocardial Infarction (AMI) is the most serious among the cardiovascular causes of mortality following the attack of influenza, mainly in patients with various co-morbidities like pre-existing coronary artery disease (CAD), diabetes mellitus (DM), hypertension (HTN) and heart failure (HF). We have reviewed the association between influenza virus infection and AMI and extrapolated the beneficial effects of influenza vaccine in preventing AMI and its grave consequences

Recommended Citation

Baral, Nischit; Sharma, Suman; Ghimire, Subash; Poudel, Sanjay; Hamal, Savyata; Baral, Nisha; and Nayak, Niranjan (2019) "Acute myocardial infarction triggered by influenza: Role of vaccine in its prevention," Manipal Journal of Medical Sciences: Vol. 4: Iss. 1, Article 3.
Available at: https://impressions.manipal.edu/mjms/vol4/iss1/3